Even the new superfluous features in i Message, like resizing messages, invisible ink, heartbeats, and strobe effects, are presumably things Apple built to delight people.Look at this conversation, in a press image from Apple’s i OS 10 announcement. Does Apple want to only delight its hardware customers, or to delight everyone? Years ago I said something in anger on a podcast, and I think it's actually kind of true: Let me be clear here.
Onxeo’s objective is to become a major international player in the field of rare cancers.
Its growth strategy is founded on the development of innovative, effective, and safe drugs based on breakthrough technologies that can make a real difference in the treatment of orphan oncology diseases and considerably improve the quality of life of patients affected by rare or resistant cancers.
Apple can't get everyone to buy an i Phone, but everyone could use i Message.
Doesn't Apple want to be there for those times, too?
For a discussion of risks and uncertainties which could cause actual results, financial condition, performance or achievements of Onxeo to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the 2016 Reference Document filed with the AMF on April 24, 2017, which is available on the AMF website ( or on the company’s website (
And so I have a simple question for Tim in response: what could a tech company do that's more life-enriching and humanity-lifting than allow people to talk to each other?
This nanoparticle formulation provides new and promising properties, including overcoming the mechanisms of chemoresistance developed by tumor cells that affect the efficacy of chemotherapy agents. The new patent provides protection of the associated claims in the U. until 2032, and is in addition to the previously issued patents for the same patent family in other major territories, such as Europe and Japan.
(Euronext Paris: ONXEO) (NASDAQ Copenhagen: ONXEO), a clinical-stage biotechnology company specializing in the development of innovative drugs for the treatment of orphan diseases, in particular in oncology, today announced that it has received a Notice of Allowance from the U. Patent and Trademark Office for a patent application covering the specific route of administration for Livatag (doxorubicin Transdrug™) is based on an innovative technology allowing the formulation of doxorubicin (a chemotherapeutic agent) within nanoparticles composed of polyalkylcyanoacrylate, cyclodextrin, and poloxamer.
In that case, at least everyone can have the schadenfreude of me complaining about Bing for a year.
Disclaimer: If Apple ports i Message to Android but doesn’t directly inform me that Tim Cook was persuaded by my argument, I’m totally not going to use Bing for a year.
There's only one way to achieve the latter: make services that are available to all people, not just people who buy Apple hardware. It didn't mean this company didn't want to succeed, or that it didn't want people's money.